These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing. Vorsters A, Van Keer S, Biesmans S, Hens A, De Coster I, Goossens H, Ieven M, Van Damme P. Int J Mol Sci; 2016 May 17; 17(5):. PubMed ID: 27196899 [Abstract] [Full Text] [Related]
23. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR]. Sahiner F, Gümral R, Sener K, Yiğit N, Dede M, Yapar M, Kubar A. Mikrobiyol Bul; 2012 Oct 17; 46(4):624-36. PubMed ID: 23188576 [Abstract] [Full Text] [Related]
24. The prevalence of human papillomavirus (HPV) infection in paired urine and cervical smear samples of HIV-infected women. Jong E, Mulder JW, van Gorp EC, Wagenaar JK, Derksen J, Westerga J, Tol A, Smits PH. J Clin Virol; 2008 Feb 17; 41(2):111-5. PubMed ID: 18354821 [Abstract] [Full Text] [Related]
27. [Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study]. Kahng J, Lee HJ. Korean J Lab Med; 2008 Feb 17; 28(1):70-8. PubMed ID: 18309258 [Abstract] [Full Text] [Related]
28. Genotypes distribution of human papillomavirus in cervical samples of Ecuadorian women. García Muentes GD, García Rodríguez LK, Burgos Galarraga RI, Almeida Carpio F, Ruiz Cabezas JC. Rev Bras Epidemiol; 2016 Mar 17; 19(1):160-6. PubMed ID: 27167657 [Abstract] [Full Text] [Related]
29. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems. Payan C, Ducancelle A, Aboubaker MH, Caer J, Tapia M, Chauvin A, Peyronnet D, Le Hen E, Arab Z, Legrand MC, Tran A, Postec E, Tourmen F, Avenel M, Malbois C, De Brux MA, Descamps P, Lunel F. J Clin Microbiol; 2007 Mar 17; 45(3):897-901. PubMed ID: 17229868 [Abstract] [Full Text] [Related]
32. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ. Vaccine; 2008 Aug 19; 26 Suppl 10():K29-41. PubMed ID: 18847555 [Abstract] [Full Text] [Related]
33. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia. Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M. Vaccine; 2013 Dec 31; 31 Suppl 7():H46-58. PubMed ID: 24332297 [Abstract] [Full Text] [Related]
35. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women. Obiri-Yeboah D, Adu-Sarkodie Y, Djigma F, Hayfron-Benjamin A, Abdul L, Simpore J, Mayaud P. BMC Womens Health; 2017 Sep 26; 17(1):86. PubMed ID: 28950841 [Abstract] [Full Text] [Related]
39. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis. Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC. Cytopathology; 2009 Aug 26; 20(4):249-55. PubMed ID: 19018810 [Abstract] [Full Text] [Related]
40. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology. Castle PE, Reid J, Dockter J, Getman D. J Clin Virol; 2015 Aug 26; 69():52-5. PubMed ID: 26209379 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]